BIOLASE Announces Formation of Dental Professional

Advisory Board
IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the world's leading
manufacturer and distributor of dental lasers, today announced that as a key part of its ongoing
transformation, it has formed a new Dental Professional Advisory Board. The Advisory Board is
dedicated to improving the Company's approach to the dental profession and strengthening
BIOLASE's leadership, worldwide competitiveness, and focus on dentists and dental their patients.
The four founding members, Drs. Samuel B. Low, Howard Golan, Robert A. Lowe, and Giorgios
Romanos, have made significant contributions to the specialties of periodontics, implantology, oral
surgery, multi-stage restorative therapy, and peri-implantitis therapy. Dr. Low will serve as Advisory
Board Chairman.
Dr. Low said, "I look forward to assisting BIOLASE in achieving Boston dentist its goals by chairing
the Advisory Board. Technology and its benefits are the core values for the present and future of
health care, and I have been a WaterLase laser system user
http://www.bestdentistguide.com/dentist/1346-dental-solutions for close to a decade. WaterLase
technology should be the standard of care in nearly all routine dental procedures."
"The decision to form the Dental Professional Advisory Board is evidence of our renewed
commitment to the dental industry," said Acting CEO Jeffrey M. Nugent, "and our recognition that
our decision making should be guided by dental practitioners of the highest caliber and at the top of
their respective subspecialties. The versatility of WaterLase as well as our other current and
pipeline of products makes it a practical necessity to get frequent input from dentists, particularly as
we put this business on a positive growth trajectory and help define the future of dentistry."
The new Advisory Board will work directly with BIOLASE President and COO Alexander K. Arrow,
MD., and counsel the Company on product development and key elements of its interactions with its
dental customers and their patients. Dr. Arrow noted that BIOLASE is committed to ensuring that its
customer service is a recognized strength of the Company, and that BIOLASE is not only known as
the company with the best all-tissue dental laser, but that it champions evidence-based dentistry and
takes exceptional care of its customers.
Samuel B. Low, D.D.S. M.S. M.Ed, Chairman of the Dental Professional Advisory Board, is Professor
Emeritus of Periodontology at the University of Florida's College of Dentistry with previous positions
of Graduate Director and Associate Dean for Administrative Affairs including a practice of
periodontics, lasers and implant dentistry. He is a past President of the American Academy of
Periodontology and the Florida Dental Association and a former Trustee of the American Dental
Association. With significant publications and patents, he is on editorial boards and is a national and
international recognized speaker.
Dr. Robert A. Lowe D.D.S. is a practicing restorative dentist who has pioneered techniques in laser
crown lengthening, particularly in closed flap procedures. He has almost three decades of
experience as a dental clinician and educator. He has received multiple honors from his peers
including Diplomate status on the American Board of Aesthetic Dentistry, an honor shared by fewer
than 50 dentists in the United States. Dr. Lowe has consistently appeared on Dentistry Today's
annual list of "Top 100 Clinicians In Dentistry." He has been awarded fellowships from the
International Academy of Dento-Facial Aesthetics, the International College of Dentists, the
Academy of Dentistry International, the Pierre Fauchard Academy, the Academy of General
Dentistry, and the American College of Dentists.
Giorgios Romanos, D.D.S., Ph.D., Prof. Dr. med. dent. is a full Professor in the Dept. of
Periodontology at the Stony Brook School of Dental Medicine. Prof. Romanos has published more
than 200 journal articles and book chapters, four textbooks on implant dentistry and laser dentistry,
and has held multiple teaching positions at universities in Germany, as well as NYU, Rochester and
currently, at Stony Brook University.
Prof. Romanos has been awarded advanced certificates in Periodontology, Prosthodontics and Oral
Surgery in both the U.S. and Europe, and with Board Certifications in Oral Surgery and
Periodontology. He has been awarded fellowships from the Academy of Osseointegration, the
International College of Dentists, the International College of Oral Implantologists and the American
Society for Laser Medicine and Surgery.
Howard Golan, D.D.S., J.D., is a restorative dentist who lectures and teaches across the country and
internationally about the benefits of laser-assisted dentistry, including quick and productive
integration of laser-assisted dentistry, minimally invasive concepts and CAD/CAM technology into
dental practices. He is the co-founder of the Center for Laser Education and is a faculty member
with the World Clinical Laser Institute teaching Certification Training Courses for that organization.
Dr. Golan practices and teaches a Biomimetic philosophy aimed at conserving tooth, soft tissue and
bone. He maintains a busy private practice on Long Island that he shares with his father, Dr.
Marshall Golan. Dr. Golan implemented lasers into his practice in 2004 and CAD/CAM in 2007, and
attained his Mastership certification in the World Clinical Laser Institute. Dr. Golan completed a
Fellowship in Implant Surgery and Advanced Prosthetics at North Shore University Hospital in New
York.
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical device company that develops, manufactures, and markets innovative
lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital
imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers.
BIOLASE's products are focused on technologies that advance the practice of dentistry and medicine
and offer benefits and value to healthcare professionals and their patients. The Company's
proprietary laser products incorporate approximately 300 patented and patent-pending technologies
designed to provide biologically clinically superior performance with less pain and faster recovery
times. Its innovative products provide cutting-edge technology at competitive prices to deliver the
best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser
systems that perform a broad range of dental procedures, including cosmetic and complex surgical
applications, and a full line of dental imaging equipment. BIOLASE has sold more than 26,000 laser
systems. Laser products under development address the Company's core dental market and other
adjacent medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at
www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Google+ at
www.google.com/+BIOLASEIrvine, Instagram at www.instagram.com/biolaseinc, and YouTube at
www.youtube.com/biolasevideos.
BIOLASE and WaterLase are registered trademarks of BIOLASE, Inc.
Cautionary Note Regarding Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the safe harbor
provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements
can be identified through the use of words such as "anticipates," "expects," "intends," "plans,"
"believes," "aims," "estimates," "may," "will," and variations of these words or similar expressions.
Readers are cautioned not to place undue reliance on these forward-looking statements, which are
based on BIOLASE's current expectations, speak only as of the date of this release and are subject to
risks, uncertainties and other factors that may cause BIOLASE's actual results to differ materially
from the statements contained in this press release, including those other risks, uncertainties and
other factors described in Item 1A of BIOLASE's annual report on Form 10-K for the fiscal year
ended December 31, 2013, filed with the Securities and Exchange Commission. Except as required
by law, BIOLASE undertakes no obligation to update, amend or clarify any forward-looking
statements to reflect events, new information or circumstances occurring after the issuance of this
release.